Cargando…

Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function

Primaquine prevents relapses of Plasmodium vivax malaria but can cause severe hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. The clinical and laboratory features of this outcome are usually confounded by the clinical and hemolytic effects of concomitant malaria. We d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, Nicholas M., Piera, Kim A., Rumaseb, Angela, Ley, Benedikt, Anstey, Nicholas M., Price, Ric N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2023
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833077/ https://www.ncbi.nlm.nih.gov/pubmed/36509054 http://dx.doi.org/10.4269/ajtmh.21-0834

Ejemplares similares

A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum
por: Rumaseb, Angela, et al.
Publicado: (2022)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Barriers to routine G6PD testing prior to treatment with primaquine
por: Ley, Benedikt, et al.
Publicado: (2017)

Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses
por: Yilma, Daniel, et al.
Publicado: (2023)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2017)

Modelling primaquine-induced haemolysis in G6PD deficiency
por: Watson, James, et al.
Publicado: (2017)

A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
por: Sadhewa, Arkasha, et al.
Publicado: (2023)

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018)

Asymmetric Dimethylarginine in Adult Falciparum Malaria: Relationships With Disease Severity, Antimalarial Treatment, Hemolysis, and Inflammation
por: Barber, Bridget E., et al.
Publicado: (2016)

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
por: Avalos, Sara, et al.
Publicado: (2018)

Improving Case Definitions for Severe Malaria
por: Anstey, Nicholas M, et al.
Publicado: (2007)

Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation
por: Alam, Mohammad Shafiul, et al.
Publicado: (2018)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
por: Devine, Angela, et al.
Publicado: (2017)

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2019)

G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials
por: Sepúlveda, Nuno, et al.
Publicado: (2021)

No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency()
por: Schilling, William H.K., et al.
Publicado: (2020)

G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study
por: Ley, Benedikt, et al.
Publicado: (2016)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

Absence of gender influence on the pharmacokinetics of chloroquine combined with primaquine in malaria vivax patients
por: Vieira, Michelle Valeria Dias Ferreira, et al.
Publicado: (2020)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
por: Engel, Nora, et al.
Publicado: (2021)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Methods for the field evaluation of quantitative G6PD diagnostics: a review
por: Ley, Benedikt, et al.
Publicado: (2017)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)

G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2021)

The anaemia of Plasmodium vivax malaria
por: Douglas, Nicholas M, et al.
Publicado: (2012)

Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients
por: Macêdo, Marielle M., et al.
Publicado: (2023)

Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2023)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
por: Commons, Robert J, et al.
Publicado: (2020)

Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens
por: Chu, Cindy S., et al.
Publicado: (2017)

Imported Tertian Malaria Resistant to Primaquine
por: Na, Dong Jib, et al.
Publicado: (1999)

Rational malaria chemoprophylaxis – The position of primaquine
por: Baird, J. Kevin
Publicado: (2017)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
por: Douglas, Nicholas M., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure
por: Devine, Angela, et al.
Publicado: (2020)

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcadi64knatju47orp7o2emabp